Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth

	Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth
	Lan, Xiaoying; Song, Wenbin; Lu, Xiaoyu; Liu, Shouting; Liu, Jinbao; Wang, Xuejun; Liu, Ningning; Li, Xiaofen; Huang, Hongbiao; Zhao, Chong
刊名	ONCOTARGET
	2014
卷号	5 期号:14 页码:5453-5471
ISSN号	1949-2553
学科主题	Oncology ; Cell Biology
语种	英语
内容类型	期刊论文
源URL	[http://ir.foo.ac.cn/handle/2SETSVCV/658]
专题	中国科学院广州生物医药与健康研究院
推荐引用方式 GB/T 7714	Lan, Xiaoying,Song, Wenbin,Lu, Xiaoyu,et al. Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth[J]. ONCOTARGET,2014,5(14):5453-5471.
APA	Lan, Xiaoying.,Song, Wenbin.,Lu, Xiaoyu.,Liu, Shouting.,Liu, Jinbao.,...&Chen, Xin.(2014).Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth.ONCOTARGET,5(14),5453-5471.
MLA	Lan, Xiaoying,et al."Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth".ONCOTARGET 5.14(2014):5453-5471.